HTA67 Evidence Gaps in Evaluating Comparative Effectiveness, Safety, and Cost-Effectiveness of Biologics in Health Technology Assessment (HTA) Submissions for the Treatment of Severe Asthma

Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.1496
https://www.valueinhealthjournal.com/article/S1098-3015(23)01596-6/fulltext
Section Title :
Section Order : 10900
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01596-6&doi=10.1016/j.jval.2023.03.1496
HEOR Topics :
Tags :
Regions :